Cargando…

Corrigendum: Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study

Detalles Bibliográficos
Autores principales: Oh, Kyunghwan, Hong, Hee Seung, Ham, Nam Seok, Lee, Jungbok, Park, Sang Hyoung, Yang, Suk-Kyun, Yoon, Hyuk, Kim, You Sun, Choi, Chang Hwan, Ye, Byong Duk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169515/
https://www.ncbi.nlm.nih.gov/pubmed/37139592
http://dx.doi.org/10.5217/ir.2021.00173.e
_version_ 1785039057321984000
author Oh, Kyunghwan
Hong, Hee Seung
Ham, Nam Seok
Lee, Jungbok
Park, Sang Hyoung
Yang, Suk-Kyun
Yoon, Hyuk
Kim, You Sun
Choi, Chang Hwan
Ye, Byong Duk
author_facet Oh, Kyunghwan
Hong, Hee Seung
Ham, Nam Seok
Lee, Jungbok
Park, Sang Hyoung
Yang, Suk-Kyun
Yoon, Hyuk
Kim, You Sun
Choi, Chang Hwan
Ye, Byong Duk
author_sort Oh, Kyunghwan
collection PubMed
description
format Online
Article
Text
id pubmed-10169515
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Korean Association for the Study of Intestinal Diseases
record_format MEDLINE/PubMed
spelling pubmed-101695152023-05-11 Corrigendum: Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study Oh, Kyunghwan Hong, Hee Seung Ham, Nam Seok Lee, Jungbok Park, Sang Hyoung Yang, Suk-Kyun Yoon, Hyuk Kim, You Sun Choi, Chang Hwan Ye, Byong Duk Intest Res Corrigendum Korean Association for the Study of Intestinal Diseases 2023-04 2023-04-28 /pmc/articles/PMC10169515/ /pubmed/37139592 http://dx.doi.org/10.5217/ir.2021.00173.e Text en © Copyright 2023. Korean Association for the Study of Intestinal Diseases. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Corrigendum
Oh, Kyunghwan
Hong, Hee Seung
Ham, Nam Seok
Lee, Jungbok
Park, Sang Hyoung
Yang, Suk-Kyun
Yoon, Hyuk
Kim, You Sun
Choi, Chang Hwan
Ye, Byong Duk
Corrigendum: Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study
title Corrigendum: Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study
title_full Corrigendum: Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study
title_fullStr Corrigendum: Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study
title_full_unstemmed Corrigendum: Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study
title_short Corrigendum: Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study
title_sort corrigendum: real-world effectiveness and safety of ustekinumab induction therapy for korean patients with crohn’s disease: a kasid prospective multicenter study
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169515/
https://www.ncbi.nlm.nih.gov/pubmed/37139592
http://dx.doi.org/10.5217/ir.2021.00173.e
work_keys_str_mv AT ohkyunghwan corrigendumrealworldeffectivenessandsafetyofustekinumabinductiontherapyforkoreanpatientswithcrohnsdiseaseakasidprospectivemulticenterstudy
AT hongheeseung corrigendumrealworldeffectivenessandsafetyofustekinumabinductiontherapyforkoreanpatientswithcrohnsdiseaseakasidprospectivemulticenterstudy
AT hamnamseok corrigendumrealworldeffectivenessandsafetyofustekinumabinductiontherapyforkoreanpatientswithcrohnsdiseaseakasidprospectivemulticenterstudy
AT leejungbok corrigendumrealworldeffectivenessandsafetyofustekinumabinductiontherapyforkoreanpatientswithcrohnsdiseaseakasidprospectivemulticenterstudy
AT parksanghyoung corrigendumrealworldeffectivenessandsafetyofustekinumabinductiontherapyforkoreanpatientswithcrohnsdiseaseakasidprospectivemulticenterstudy
AT yangsukkyun corrigendumrealworldeffectivenessandsafetyofustekinumabinductiontherapyforkoreanpatientswithcrohnsdiseaseakasidprospectivemulticenterstudy
AT yoonhyuk corrigendumrealworldeffectivenessandsafetyofustekinumabinductiontherapyforkoreanpatientswithcrohnsdiseaseakasidprospectivemulticenterstudy
AT kimyousun corrigendumrealworldeffectivenessandsafetyofustekinumabinductiontherapyforkoreanpatientswithcrohnsdiseaseakasidprospectivemulticenterstudy
AT choichanghwan corrigendumrealworldeffectivenessandsafetyofustekinumabinductiontherapyforkoreanpatientswithcrohnsdiseaseakasidprospectivemulticenterstudy
AT yebyongduk corrigendumrealworldeffectivenessandsafetyofustekinumabinductiontherapyforkoreanpatientswithcrohnsdiseaseakasidprospectivemulticenterstudy
AT corrigendumrealworldeffectivenessandsafetyofustekinumabinductiontherapyforkoreanpatientswithcrohnsdiseaseakasidprospectivemulticenterstudy